Abstract: There is disclosed a method of treating affected external or surface tissue comprising the steps of providing a source of affected external or surface tissue; generating a source of microwave energy; transmitting said microwave energy into said affected external or surface tissues; exposing said affected external and surface tissues to said microwave energy to raise the local temperature to thereby ablate, remove, coagulate or otherwise alter said affected external and surface tissues.
Type:
Grant
Filed:
July 9, 2021
Date of Patent:
February 28, 2023
Assignee:
Atlantic Cancer Research Institute
Inventors:
J. R. Jocelyn Paré, Jacqueline M. R. Bélanger
Abstract: There is disclosed a method of treating affected external or surface tissue comprising the steps of providing a source of affected external or surface tissue; generating a source of microwave energy; transmitting said microwave energy into said affected external or surface tissues; exposing said affected external and surface tissues to said microwave energy to raise the local temperature to thereby ablate, remove, coagulate or otherwise alter said affected external and surface tissues.
Type:
Application
Filed:
July 9, 2021
Publication date:
December 16, 2021
Applicant:
ATLANTIC CANCER RESEARCH INSTITUTE
Inventors:
J.R. Jocelyn PARÉ, Jacqueline M. R. BÉLANGER
Abstract: There is disclosed a method of treating affected external or surface tissue comprising the steps of providing a source of affected external or surface tissue; generating a source of microwave energy; transmitting said microwave energy into said affected external or surface tissues; exposing said affected external and surface tissues to said microwave energy to raise the local temperature to thereby ablate, remove, coagulate or otherwise alter said affected external and surface tissues.
Type:
Grant
Filed:
April 5, 2017
Date of Patent:
August 17, 2021
Assignee:
Atlantic Cancer Research Institute
Inventors:
J. R. Jocelyn Paré, Jacqueline M. R. Bélanger
Abstract: The present application relates to methods for the isolation of EVs from a sample containing EVs, the method comprising: (i) contacting the sample with one or more polyethylenimines to form an EV-polyethylenimine complex; and (ii) separating the EV-polyethylenimine complex from the sample. Also included in the application are kits for performing the methods for isolating EVs and methods of diagnosis and therapy using the EVs isolated using the described methods.
Type:
Application
Filed:
May 17, 2019
Publication date:
August 5, 2021
Applicant:
Atlantic Cancer Research Institute (ACRI)
Abstract: The present disclosure relates to a method for the isolation of microvesicles comprising contacting the sample with at least one polysaccharide to isolate the microvesicles.
Abstract: There is disclosed a method of treating affected external or surface tissue comprising the steps of providing a source of affected external or surface tissue; generating a source of microwave energy; transmitting said microwave energy into said affected external or surface tissues; exposing said affected external and surface tissues to said microwave energy to raise the local temperature to thereby ablate, remove, coagulate or otherwise alter said affected external and surface tissues.
Type:
Application
Filed:
April 5, 2017
Publication date:
November 7, 2019
Applicant:
ATLANTIC CANCER RESEARCH INSTITUTE
Inventors:
J.R. Jocelyn PARÉ, Jacqueline M. R. BÉLANGER
Abstract: The present application is directed to a peptides comprising an a-helix forming-amino acid sequence that binds a heat shock protein. Also included is a polypeptide comprising (a) a first peptide portion that comprises an ?-helix-forming amino acid sequence that binds a heat shock protein; and (b) at least one second peptide portion comprising an antigenic amino acid sequence and/or an a-helix-stabilizing amino acid sequence that increases the interaction of the first peptide portion with the heat shock protein. The present application also includes compositions comprising the peptides and/or polypeptides of present application and uses of the peptides and/or polypeptides of the present application for fractionating substances relevant for discovery, research or clinical analysis from a biological sample and as therapeutics.
Type:
Grant
Filed:
March 21, 2012
Date of Patent:
February 17, 2015
Assignees:
Atlantic Cancer Research Institute, New England Peptide, Inc.
Inventors:
Steven Gareth Griffiths, Scott Edwin Lewis